Evidence map›Paper›PMID 37887334›Full record

ArticleCells2023

Autoantibodies Which Bind to and Activate Keratinocytes in Systemic Sclerosis.

Carine Moezinia, Valerie Wong, James Watson, Lydia Nagib, Sandra Lopez Garces, Siyu Zhang, Bahja Ahmed Abdi, Florence Newton, David Abraham, Richard Stratton

Open access · goldAbstract read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Carine MoeziniaUCL Centre for Rheumatology, Royal Free Hospital, UCL Division of Medicine, London NW3 2QG, UK.
Valerie WongUCL Centre for Rheumatology, Royal Free Hospital, UCL Division of Medicine, London NW3 2QG, UK.
James WatsonUCL Centre for Rheumatology, Royal Free Hospital, UCL Division of Medicine, London NW3 2QG, UK.
Lydia NagibUCL Centre for Rheumatology, Royal Free Hospital, UCL Division of Medicine, London NW3 2QG, UK.
Sandra Lopez GarcesUCL Centre for Rheumatology, Royal Free Hospital, UCL Division of Medicine, London NW3 2QG, UK.
Siyu ZhangUCL Centre for Rheumatology, Royal Free Hospital, UCL Division of Medicine, London NW3 2QG, UK.
Bahja Ahmed AbdiUCL Centre for Rheumatology, Royal Free Hospital, UCL Division of Medicine, London NW3 2QG, UK.
Florence NewtonUCL Centre for Rheumatology, Royal Free Hospital, UCL Division of Medicine, London NW3 2QG, UK.
David AbrahamUCL Centre for Rheumatology, Royal Free Hospital, UCL Division of Medicine, London NW3 2QG, UK.ORCID 0000-0001-8952-6057
Richard StrattonUCL Centre for Rheumatology, Royal Free Hospital, UCL Division of Medicine, London NW3 2QG, UK.ORCID 0000-0002-2948-6919
The Royal Free Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic sclerosis (SSc) is a multisystem connective tissue disease characterised by pathological processes involving autoimmunity, vasculopathy and resultant extensive skin and organ fibrosis. Recent studies have demonstrated activation and aberrant wound healing responses in the epithelial layer of the skin in this disease, implicating the epithelial keratinocytes as a source of pro-fibrotic and inflammatory mediators. In this paper, we investigated the role of Immunoglobulin G (IgG) autoantibodies directed against epithelial cells, as potential initiators and propagators of pathological keratocyte activation and the ensuing SSc fibrotic cascade. A keratinocyte cell-based ELISA is used to evaluate the binding of SSc IgG. SSc skin biopsies were stained by immunofluorescence for the presence of IgG in the keratinocyte layer. Moreover, IgG purified from SSc sera was evaluated for the potential to activate keratinocytes in tissue culture and to induce TLR2 and 3 signalling in reporter cell lines. We demonstrate enhanced binding of SSc IgG to keratinocytes and the activation of these cells leading to the release of IL-1α, representing a potential initiating pathway in this disease.

Indexed as

AutoantibodiesScleroderma, SystemicFibrosisHumansImmunoglobulin GKeratinocytesAutoantibodiesImmunoglobulin Gautoantibodyepithelial cellfibrosisscleroderma

Identifiers

PMID37887334
PMCPMC10605821
OpenAlexW4387820132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.